Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients.
about
Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategiesPrognostic significance of a comprehensive histologic evaluation of reticulin fibrosis, collagen deposition and osteosclerosis in primary myelofibrosis patients.Bone marrow fibrosis grade is an independent risk factor for overall survival in patients with primary myelofibrosis.Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms.Prognostic impact of bone marrow fibrosis in polycythemia vera: validation of the IWG-MRT study and additional observations.Baseline factors associated with response to ruxolitinib: an independent study on 408 patients with myelofibrosis.Chronic Myeloid Leukemia with an e6a2 BCR-ABL1 Fusion Transcript: Cooperating Mutations at Blast Crisis and Molecular Monitoring.Moderate anemia at diagnosis is an independent prognostic marker of the EUTOS, Sokal, and Hasford scores for survival and treatment response in chronic-phase, chronic myeloid leukemia patients with frontline imatinib.Prefibrotic versus overtly fibrotic primary myelofibrosis: clinical, cytogenetic, molecular and prognostic comparisons.SOHO State-of-the-Art Update and Next Questions: MPN.Prognostication in Philadelphia Chromosome Negative Myeloproliferative Neoplasms: a Review of the Recent Literature.A phase 2 study of simtuzumab in patients with primary, post-polycythaemia vera or post-essential thrombocythaemia myelofibrosis.Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis.The prognostic impact of bone marrow fibrosis in primary myelofibrosis.
P2860
Q26744113-DEFE10FA-19EA-4992-A85F-025842F0EF63Q33443649-DF33E00E-A17D-4E9F-A5DF-C71B1E735F03Q37575948-BEA6E400-FF47-4C42-80AE-443E37C3C602Q37679175-CB17B8D8-D135-4F1F-9BF0-5663ADBCADB1Q42292798-B7938E20-AA10-4C51-89F4-463B0B0B129BQ45236578-D4BD4DBC-C250-4F11-8CA8-48B45ABD62FEQ47132357-11381005-831E-43C2-9B17-B1D9BC2A0B1FQ47824125-5DC8601F-0B17-428F-B667-7D7044DDCCA2Q48176317-8FD29964-B961-4206-A4CA-C10B473AD7C5Q49580473-245C82E3-0EB2-4CB5-BBD1-936EF16A4E47Q49834487-4E027E5A-BDAC-4FF1-B2C7-3038616EF1C4Q51129616-A9199013-5A38-42C1-88D0-40A918DA1205Q51733623-2881F57D-5362-4E30-9C3D-490F7B79DC48Q53079228-D25B00D2-67DE-45A4-BA54-36BC8EED8806
P2860
Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Prognostic impact of bone marr ...... e AGIMM group on 490 patients.
@ast
Prognostic impact of bone marr ...... e AGIMM group on 490 patients.
@en
type
label
Prognostic impact of bone marr ...... e AGIMM group on 490 patients.
@ast
Prognostic impact of bone marr ...... e AGIMM group on 490 patients.
@en
prefLabel
Prognostic impact of bone marr ...... e AGIMM group on 490 patients.
@ast
Prognostic impact of bone marr ...... e AGIMM group on 490 patients.
@en
P2093
P2860
P50
P356
P1476
Prognostic impact of bone marr ...... he AGIMM group on 490 patients
@en
P2093
Alessandro M Vannucchi
Alessandro Rambaldi
Annalisa Pacilli
Daniela Cilloni
Elisa Rumi
Emanuela Sant'Antonio
Giada Rotunno
Giovanni Barosi
Margherita Maffioli
Mario Cazzola
P2860
P304
P356
10.1002/AJH.24442
P50
P577
2016-07-04T00:00:00Z